SCHEMBL8869375

SCHEMBL8869375

COCCNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(CCNC(C)=O)cc2)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 2/20 0.51
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.47
LMNA P02545 2/20 0.47
CYP3A4 P08684 1/20 0.47
HTR1A P08908 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
TSHR P16473 1/20 0.47
NFKB1 P19838 1/20 0.47
CNR1 P21554 1/20 0.47
CYP2C19 P33261 1/20 0.47
ADRA1A P35348 1/20 0.47
BLM P54132 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
POLB P06746 1/20 0.45
EGFR P00533 2/20 0.44
TP53 P04637 1/20 0.43
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868547 0.92 P4HTM (0.47) P4HTMKMT2AMEN1LMNACYP3A4
SCHEMBL8869478 0.91 P4HTM (0.49) P4HTMKMT2AMEN1LMNACYP3A4
SCHEMBL8868425 0.90 P4HTM (0.53) P4HTMKMT2AMEN1LMNAMAPT
SCHEMBL8869604 0.90 EGFR (0.53) P4HTMKMT2AMEN1LMNAMAPT
SCHEMBL8869577 0.90 EGFR (0.53) P4HTMKMT2AMEN1LMNAMAPT
SCHEMBL8870118 0.90 P4HTM (0.48) P4HTMKMT2AMEN1LMNACYP3A4
SCHEMBL8869630 0.90 MAPT (0.53) P4HTMKMT2AMEN1LMNACYP3A4
SCHEMBL8868352 0.90 P4HTM (0.61) P4HTMKMT2AMEN1LMNAMAPT
SCHEMBL8868306 0.90 MAPT (0.53) P4HTMKMT2AMEN1LMNACYP3A4
SCHEMBL8868528 0.89 P4HTM (0.50) P4HTMKMT2AMEN1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed